# A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)

> **NCT04816890** · PHASE2 · COMPLETED · sponsor: **Adocia** · enrollment: 80 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** M1 Pram P037
- **DRUG:** Insulin lispro

## Key facts

- **NCT ID:** NCT04816890
- **Lead sponsor:** Adocia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-23
- **Primary completion:** 2022-02-24
- **Final completion:** 2022-02-24
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04816890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04816890, "A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04816890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*